カタログ製品コード : C-EK11932
Human Apolipoprotein H/Apo H ELISA kit
24T | ¥47,000 | (¥1,958/T) (税別) |
48T | ¥61,000 | (¥1,271/T) (税別) |
96T | ¥69,800 | (¥727/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK11932
Human Apolipoprotein H/Apo H ELISA kit
24T | ¥47,000 | (¥1,958/T) (税別) |
48T | ¥61,000 | (¥1,271/T) (税別) |
96T | ¥69,800 | (¥727/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | Apolipoprotein H/Apo H | Human | 125 - 8000 pg/ml | 50 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against Apo H |
Human Apo H Standard, lyophilized |
Apo H Detect Antibody |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
Washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,Beta-2-glycoprotein 1,APC inhibitor,Activated protein C-binding protein,Anticardiolipin cofactor,Apolipoprotein H,Apo-H,Beta-2-glycoprotein I,B2GPI,Beta(2)GPI,APOH,B2G1
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human Apo H. The Human Apolipoprotein H/Apo H ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Apolipoprotein H (Apo H), previously known as β2-glycoprotein I, is a multifunctional apolipoprotein that in humans is encoded by the APOH gene. It is a glycoprotein synthesized by liver cells. One of its functions is to bind cardiolipin. Apo H binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. Apo H has a complex involvement in agglutination, it appears to alter ADP mediated agglutination of platelets. It may prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. Normally Apo H assumes an anti-coagulation activity in serum (by inhibiting coagulation factors). Its plasma concentrations are strongly associated to metabolic syndrome alterations and vascular disease in type 2 diabetic and could be considered as a clinical marker of cardiovascular risk.